Bharat Biotech’s Covaxin got approval for Phase 2/3 Trials On 2-18-Year-Olds
Hyderabad: Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on ...
Tag: Phase 2/3 Trials
Hyderabad: Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on ...